C

Cell Signaling Technology

Antibody development and validated research tools

Associate Director - Strategic Marketing, Biopharma & CRO Solutions

Full-TimePosted on 10/19/2026
$178k - $227k/yr+ 401(k) with 6% match
Expert
Master's, MBA, PhD
Danvers, MA, USA
In Person
Growth & MarketingProduct Marketing

About the job

Requirements
  • An advanced degree (Master's or PhD) in life sciences, such as molecular biology or biochemistry, or a related field.
  • At least 10 years of experience in the life sciences industry, including hands-on experience using antibody-based products and services in an industry setting such as BioPharma or a CRO.
  • At least 5 years of experience managing a portfolio, including proven experience managing a service portfolio such as custom or contract services.
  • Experience managing or leading a team, ideally including product management or product marketing roles.
  • Direct BioPharma or CRO experience through employment, selling, or close partnership with those organizations.
  • Experience with portfolio performance management, including revenue, margin, and lifecycle tracking.
  • Experience working with global sales channels and distributors.
  • Strong people leadership skills and a track record of building, coaching, and developing high-performing teams.
  • Deep technical expertise in antibody-based products and services, applied to portfolio and commercial decisions.
  • Strong portfolio performance management skills and a data-driven approach to prioritization.
  • Strong communication and presentation skills, including the ability to simplify scientific and commercial concepts for diverse audiences.
  • Commitment to quality and continuous improvement in portfolio planning and delivery.
  • Ability to build strong cross-functional relationships.
  • Strong problem-solving skills and willingness to consider unconventional approaches.
  • Comfort working in a dynamic, fast-paced environment.
Responsibilities
  • Develop a deep understanding of BioPharma and CRO customer segments, quantifying segment size, growth drivers, and technology trends.
  • Architect and execute a market research strategy using voice-of-customer interviews, surveys, and advisory boards to generate actionable insights that guide portfolio investment.
  • Lead, coach, and develop a team of two—a Product Manager and a Product Marketing Manager—setting clear goals and priorities and collaborating closely with the Custom Solutions Lead.
  • Manage, expand, and maintain the roadmap for CST's antibody-based product portfolio supporting BioPharma discovery and clinical applications across modality, workflow, platform, and disease area, and build the business case for new portfolio additions.
  • Own the end-to-end strategy, roadmap, and commercialization of custom and customized services, including conjugation, mass spectrometry services, format and buffer customization, and custom antibody discovery and engineering, in partnership with the Custom Solutions Lead.
  • Build and present data-driven business cases for expanding into new custom capabilities.
  • Define pricing, contracting, and tiered service models for BioPharma and CRO buyers.
  • Partner cross-functionally to ensure product supply and custom service capacity, service-level agreements, and delivery standards meet BioPharma and CRO expectations.
  • Own positioning and messaging of CST's reagent portfolio for BioPharma and CRO buyers, translating product value into propositions aligned with buyer workflows and priorities.
  • Develop segment-specific value propositions that account for the regulatory context, quality expectations, and procurement models of BioPharma and CRO customers.
  • Direct the creation of campaigns, collateral, and sales tools that drive adoption of the portfolio and custom services among BioPharma and CRO buyers.
  • Partner with Marketing Communications to develop web, collateral, and campaign content communicating portfolio value to this segment.
  • Architect and deliver sales and distributor training so commercial teams can position the portfolio and custom services offerings.
  • Define key performance indicators and report on segment-specific marketing and custom services commercialization performance to senior leadership.
  • Build and maintain relationships with BioPharma and CRO customers and key opinion leaders to validate messaging, gather field intelligence, and inform the custom services roadmap.
  • Identify emerging needs through customer engagement and represent the BioPharma/CRO customer voice in cross-functional planning with Research and Development, Sales, and Operations.
Desired Qualifications
  • Experience with antibody-based reagents or related life science tools.
  • A Master of Business Administration.

About the company

C

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 ISO 13485 certification widens CST's regulated manufacturing addressable market.
  • June 2026 Quantum-Si partnership ties CST to next-generation proteomics validation.
  • 2026 deals with Leveragen, MJFF, and Nordic Biosite expand distribution and disease-specific demand.

What critics are saying

  • Antibody catalogs commoditize fast; Thermo Fisher and Abcam pressure CST pricing by 2027.
  • WuXi Diagnostics partnership concentrates diagnostic ambitions inside one CDx channel and regulatory bottleneck.
  • A prolonged research funding slump would choke orders and expose CST's existential dependence on academia.

What makes Cell Signaling Technology unique

  • Scientists still own CST, preserving assay credibility and product discipline.
  • ISO 13485 certification covers Beverly and Leiden, strengthening regulated reagent manufacturing.
  • SignalStar and proprietary antibody platforms keep CST embedded across spatial biology workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Company Match
  • Tuition Reimbursement
  • Unlimited Paid Time Off
  • Parental Leave
  • Employee Assistance Program
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

28%

1 year growth

28%

2 year growth

28%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.